Is Human rotavirus + Live attenuated vaccine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Human rotavirus + Live attenuated vaccine, including ROTARIX ORAL SUSPENSION VACCINE (1000000 CCID50, Oral suspension, SAR 200.65).

Active substances

Human rotavirus + Live attenuated vaccine

SFDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ROTARIX ORAL SUSPENSION VACCINE	1000000 CCID50	Oral suspension · Oral use	1 Pre-filled syringe	SAR 200.65	Biological · Prescription	GLAXO SAUDI ARABIA	Valid

Indications — CHI Daman Drug Formulary

MATERNAL AND CHILD HEALTHCARE- IMMUNIZATION FOR MOTHER AND CHILD; TRAVEL IMMUNIZATION; VIRAL GASTROENTERITIS

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.